Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Kunkel Lori Anne (CIK 1536368) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-08). Recent activity: Sell ELVN (4,111 shares), Sell ELVN (5,889 shares), Sell ELVN (7,779 shares), Sell ELVN (1,867 shares), Sell ELVN (354 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 4,111 | $205,482 |
| 2026-07-08 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 5,889 | $299,421 |
| 2026-06-09 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 7,779 | $266,664 |
| 2026-06-09 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 1,867 | $66,017 |
| 2026-06-09 | Enliven Therapeutics, Inc. (ELVN) | Director | Sell | 354 | $12,680 |
| 2025-12-19 | Enliven Therapeutics, Inc. (ELVN) | Director | Buy | 15,958 | $17,873 |
| 2025-12-09 | Oric Pharmaceuticals, Inc. (ORIC) | Director | Buy | 10,000 | $79,000 |
| 2025-12-05 | Oric Pharmaceuticals, Inc. (ORIC) | Director | Buy | 5,534 | $20,752 |
Source: SEC Form 4 filings · as of 2026-07-08